Florida Trim Clinic · Education & Evidence
Each link below identifies the topic it supports. Sources describe their own research or educational guidance, not Florida Trim Clinic’s services or patient outcomes. Their inclusion does not imply endorsement, affiliation or sponsorship.
PubMed / Diabetes, Obesity and Metabolism
Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesitySupports: Appetite, food cravings and control-of-eating findings in a small short-term semaglutide study; not a validated diagnosis of food noise or proof of specific brain-network normalization.
NIH / National Institute of Diabetes and Digestive and Kidney Diseases
Factors Affecting Weight & HealthSupports: The roles of lifestyle, sleep, medicines, health conditions, family history and genes in body weight.
Cleveland Clinic
GLP-1 AgonistsSupports: GLP-1 mechanisms, appetite and blood-sugar effects, common side effects and the need for individualized care.
NIH / National Library of Medicine — MedlinePlus
Semaglutide InjectionSupports: Semaglutide indications, administration, precautions, important warnings and adverse effects. Brand-specific instructions are not instructions for compounded products.
NIH / National Library of Medicine — MedlinePlus
Tirzepatide InjectionSupports: Tirzepatide indications, administration, precautions, important warnings and adverse effects. Individual prescribing and pharmacy instructions remain necessary.
U.S. Food and Drug Administration
FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight LossSupports: Compounded GLP-1 drugs are not FDA-approved; dosing errors, storage, ingredient and product-quality concerns; patient-specific medical need.
Blundell J, Finlayson G, Axelsen M, et al. Diabetes, Obesity and Metabolism. 2017.
Research published in Diabetes, Obesity and Metabolism reported less hunger and food craving, improved control of eating and reduced energy intake with semaglutide in a small randomized crossover study. This does not prove every proposed food-noise mechanism or establish an individual response timeline.
Florida Trim Clinic’s educational information is general and is not individualized medical advice. Prescription treatment requires evaluation by a licensed provider. Eligibility, medication selection and dosing depend on individual circumstances.
Compounded drugs are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality before marketing.
Compounded products are not FDA-approved versions of brand-name drugs, and clinical trials of approved products do not establish equivalent safety or effectiveness for compounded products. FDA registration of a facility is not FDA approval of its compounded medicines. FDA advises compounded drugs should only be used for patients whose medical needs cannot be met by an FDA-approved drug. Availability and prescribing are subject to applicable law and individual provider evaluation.
For compounded GLP-1 medicines, FDA has reported dosing errors and product-quality concerns. Semaglutide sodium and semaglutide acetate are different active ingredients from the one in approved medicines. Follow the licensed provider’s and dispensing pharmacy’s instructions; discuss dosing, storage and any adverse effects with them. Read FDA’s current compounded GLP-1 safety information.
Our Origin
South Florida Trim Clinic in Naples was the first location and the origin of the Trim Clinic Network. It started with licensed medical providers, personalized care, and no membership fees, ever.
Prescription care requires an evaluation by a licensed provider, and treatment is offered only where it is clinically appropriate and you are eligible.